SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Invesco DB Agriculture Fund - Common units of beneficial interest

Invesco DB Agriculture Fund

The Invesco DB Agriculture Fund is drawing intense interest from market participants who are betting on a prolonged food supply crisis, with many citing geopolitical tensions in the Middle East and ongoing supply chain disruptions as primary catalysts. Investors are actively debating the fund's role as an inflation hedge and speculating on potential long-term agricultural shortages, with many using the ticker as a cornerstone for bearish outlooks on broader economic stability through 2027.

GALA is designed to power the Gala Games ecosystem to support gaming re-imagined to benefit creators and players, alike.

Gala Games

Gala Games is experiencing a surge in community engagement as investors debate its potential for a major breakout, with many pointing to upcoming entertainment ecosystem catalysts and the broader gaming token narrative as potential drivers. While some community members remain skeptical of past performance, others are actively accumulating the token, anticipating that the project's utility and long-term roadmap could lead to significant momentum as the wider altcoin market matures.

Sony Group Corp. engages in the development, design, manufacture, and sale of electronic equipment, instruments, devices, game consoles, and software for consumers, professionals and industrial markets. It operates through the following segments: Game and Network Services, Music, Pictures, Home Entertainment and Sound, Imaging Products and Solutions, Mobile Communications, Semiconductors, Financial Services, and Others. The Game and Network Services segment deals with gaming machines, software and network services. The Music segment produces and publishes music and provides image media platforms. The Pictures segment handles film production, television program creation, and media networks. The Home Entertainment and Sound segment offers LCD televisions, home audio, Blu-ray Disc players and recorders, and memory-based portable audio devices. The Imaging Products and Solutions segment provides digital imaging products, professional solutions, and medical goods. The Mobile Communications segment deals with mobile phones and Internet services business. The Semiconductors segment provides image sensors and camera modules. The Financial Services segment manages the life insurance and non-life insurance operations and banking business. The Others segment includes personal computer (PC) business, overseas Blu-ray Disc, DVD and CD manufacturing, and battery business. The company was founded by Akio Morita and Masaru Ibuka on May 7, 1946 and is headquartered in Tokyo, Japan.

Sony Group Corporation - ADR

Sony Group Corporation

Sony is trending following a significant second price hike for its PlayStation 5 lineup in less than a year, sparking intense debate among investors and gamers about its pricing power and demand resilience. The community is actively discussing how these increases, alongside component cost pressures, may influence the upcoming console cycle and whether the brand can successfully offset these headwinds with its diversified entertainment and electronics portfolio.

VanEck ETF Trust - VanEck Agribusiness ETF

VanEck Agribusiness ETF

VanEck Agribusiness ETF (MOO) is capturing community attention as investors debate its role as a defensive hedge against long-term food insecurity and a potential structural bull market in agricultural commodities. Market participants are actively comparing MOO with futures-based alternatives and specific agribusiness stocks, frequently discussing its potential for a long-term breakout driven by global supply chain volatility and rising commodity prices.

PENGU is the official coin of Pudgy Penguins.  Pudgy Penguins has become the face of crypto with one of the most influential communities in the industry. From large companies wearing the Penguin, to being featured in ETF commercials, to garnering millions of followers and over 100 billion views, the Pengu has become a cultural icon making PENGU the world’s social currency.  PENGU allows for the ever-expanding Pudgy Penguin fanbase and the hundreds of millions of people outside of crypto that see and share the Pudgy Penguin everyday, to join The Huddle. PENGU is a symbol for community, memes, and good vibes.  Believe in Pengu. Believe in the Prophecy.

Pudgy Penguins

Pudgy Penguins is trending as investors debate the project's transition from a digital NFT collection into a mainstream retail brand with physical merchandise and utility-focused developments. Community members are actively discussing potential catalysts like regulatory updates and upcoming game releases, while remaining divided between those accumulating through market dips and others skeptical of price performance compared to broader crypto volatility.

Autodesk, Inc. engages in the design of software and services. Its products include AutoCAD, BIM Collaborate Pro, Revit, Civil 3D, Fusion 360, InfraWorks, Inventor, Maya, PlanGrid, Revit, Shotgun, and 3ds Max. The firm also offers product development and manufacturing software, which provides manufacturers in the automotive, transportation, industrial machinery, consumer products, and building product industries with digital design, engineering, and production solutions. The firm is also involved in digital media and entertainment, which consists of tools for digital sculpting, modeling, animation, effects, rendering, and compositing for design visualization, visual effects, and games production. The company was founded by John Walker in April 1982 and is headquartered in San Francisco, CA.

Autodesk Inc.

Autodesk is currently drawing significant investor attention as markets digest the company's recent earnings beat, raised full-year guidance, and a strategic restructuring plan that includes a workforce reduction. The community is actively debating the company's long-term growth potential and the impact of these cost-saving measures, while analysts continue to adjust price targets amidst a backdrop of ongoing institutional and activist interest.

The Cigna Group is a global health company, which engages in the provision of global health services. It operates through the following segments: Evernorth Health Services, Cigna Healthcare, Other Operations, and Corporate. The Evernorth Health Services segment partners with health plans, employers, governmental organizations, and health care providers to solve challenges in the areas of pharmacy benefits, home delivery pharmacy, specialty pharmacy, specialty distribution, and care delivery and management solutions. The Cigna Healthcare segment includes the U.S. Healthcare and International Health operating segments, which provide comprehensive medical and coordinated solutions to clients and customers. The Other Operations segment consists of the remainder of business operations, which includes certain ongoing businesses and exited businesses. The Corporate segment refers to net interest expense, certain litigation matters, expense associated with frozen pension plans, charitable contributions, operating severance, certain overhead and enterprise-wide project costs, and eliminations for products and services sold between segments. The company was founded in 1792 and is headquartered in Bloomfield, CT.

Cigna Group (The)

Cigna Corp.

Cigna is currently drawing investor attention as it solidifies its position as a defensive powerhouse, with the community actively discussing its relative strength and lack of direct Medicare exposure compared to struggling peers. Sentiment is heavily focused on the company's aggressive share buybacks, strong earnings momentum, and its strategic pivot away from government-linked programs to stabilize margins against broader sector volatility.

Featured in Matt Furies latest book Cortex Vortex as Ratos nemesis. The character is also part of ZOGZ which confirms its real name.  Matt Furie, the artist best known for creating Pepe the Frog, has been working on a new book. The news comes from his editor, who goes by the handle @beuys_on_sale_ on Instagram. In a recent post, the editor hinted at an upcoming project featuring new characters named Gasspas and Rato. Gasspas’s visual appearance can be inferred from the artwork. In one illustration, Gasspas is depicted looming over two rats (Rato and Wat), gazing down at them in a menacing way (an image that has circulated among collectors). This inferred that Gasspas is Ratos nemesis in the new book Cortex Vortex reinforced by community quips that “cats eat rats”. Gasspas debuted as part of ZOGZ, a collection of 111 original NFT character illustrations by Matt Furie launched in May 2023.

Gasspas

GASS is currently trending as speculative interest intensifies, with community members debating the project's potential for significant gains while others express frustration over liquidity issues and the perceived lack of active development. The discourse remains highly polarized, ranging from aggressive 'buy and hold' sentiment focused on zero-removal targets to warnings that the asset may be a pump-and-dump scheme.

Sprott Physical Silver Trust - Units

Sprott Physical Silver Trust ET

The community is actively discussing a significant disconnect between paper-traded silver and physical bullion, with many investors rotating from ETFs like SLV into PSLV to secure direct exposure to physical assets. Heightened geopolitical uncertainty and concerns over potential supply shortages are driving intense sentiment as traders monitor delivery data and navigate extreme volatility in the precious metals sector.

Tyson Foods, Inc. engages in the processing of prepared food and other related products. It operates through the following segments: Beef, Pork, Chicken, and Prepared Foods. The Beef segment includes processing live fed cattle and fabricating dressed beef carcasses into primal and sub-primal meat cuts and case-ready products. The Pork segment focuses on live market hogs and fabricating pork carcasses. The Chicken segment is involved in raising and processing live chickens into fresh, frozen, and value-added chicken products, and sales from specialty products. The Prepared Foods segment manufactures and markets food products and offers logistic operations to move products through the supply chain. The company was founded by John W. Tyson in 1935 and is headquartered in Springdale, AR.

Tyson Foods, Inc. - Ordinary Shares - Class A

Tyson Foods, Inc.

Tyson Foods is capturing investor attention following a mixed earnings report that highlighted operational improvements in chicken and prepared foods, despite continued profitability struggles within its beef segment. Community discussion remains focused on leadership uncertainty stemming from recent executive suspensions, concerns over the impact of high beef costs on consumer demand, and active debates about the long-term potential for a sector rotation into defensive staples.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

HC Wainwright Issues Positive Estimate for UNCY Earnings

Unicycive Therapeutics, Inc. (NASDAQ:UNCY - Free Report) - Equities research analysts at HC Wainwright increased their Q1 2026 EPS estimates for Unicycive Therapeutics in a note issued to investors on Tuesday, March 31st. HC Wainwright analyst S. Ramakanth now anticipates that the company will post...

Guggenheim Has Lowered Expectations for Unicycive Therapeutics (NASDAQ:UNCY) Stock Price

Guggenheim decreased their price target on Unicycive Therapeutics from $46.00 to $40.00 and set a "buy" rating on the stock in a research note on Thursday...

Noble Financial Has Positive Forecast for UNCY Q1 Earnings

Unicycive Therapeutics, Inc. (NASDAQ:UNCY - Free Report) - Equities research analysts at Noble Financial increased their Q1 2026 earnings per share (EPS) estimates for shares of Unicycive...

<ul class="summary-bullets"><li>The FDA is expected to decide on the application by June 29, as per the company.&nbsp;</li><li>The FDA in June refused to approve the company’s application citing manufacturing issues at a third-party manufacturing vendor.&nbsp;</li><li>The company is now looking to launch OLC in the third quarter.</li></ul>Shares of Unicycive Therapeutics Inc (UNCY) jumped 9% on Wednesday as retail investors contemplated the possibility of approval for the company’s Oxylanthanum carbonate.UNCY has resubmitted its application seeking the U.S. Food and Drug Administration’s approval for Oxylanthanum carbonate for the treatment of hyperphosphatemia in patients with chronic kidney disease on dialysis following a previous rejection. The FDA is expected to decide on the application by June 29, as per the company.The FDA in June refused to approve the company’s application citing manufacturing issues at a third-party manufacturing vendor.The company is now looking to launch OLC in the third quarter and is continuing to strengthen its commercial infrastructure and advance market readiness initiatives in the meantime.<h2 class="st-heading-2">How Did Retail Traders React?</h2>On Stocktwits, retail sentiment around UNCY jumped from ‘neutral’ to ‘bullish’ territory over the past 24 hours, while message volume increased from ‘normal’ to ‘high’ levels. Over the past week, message volume rose 150%, according to Stocktwits data.A Stocktwits user predicted revenue of as much as $600 million for OLC in 2029.<stembedurl>https://www.stocktwits.com/Thrasher5699/message/649190093</stembedurl>Yet another sees 80% chances for the drug’s approval this time.<stembedurl>https://www.stocktwits.com/Cvfiore2001/message/649096819</stembedurl><h2 class="st-heading-2">Unicycive Therapeutics Inc Management Commentary</h2>“This year is shaping up to be pivotal for Unicycive, underscored by the U.S. Food and Drug Administration’s acceptance of our New Drug Application resubmission for OLC and the potential for approval and launch later this year,” said CEO Shalabh Gupta earlier this week. “With hyperphosphatemia still uncontrolled in nearly 75% of U.S. patients with chronic kidney disease undergoing dialysis, OLC, if approved, has the potential to offer a meaningful new treatment option characterized by a differentiated clinical profile and reduced pill burden compared to currently available phosphate binders.”Hyperphosphatemia is a condition characterized by excessively high levels of phosphate in the blood.<a href="https://stocktwits.com/symbol/UNCY">UNCY stock </a>has gained nearly 32% over the past 12 months.&nbsp;Read More: <a href="https://stocktwits.com/news-articles/markets/equity/lly-stock-rallies-on-much-awaited-fda-approval-for-weight-loss-pill/cZ7Hp5ORIF5">LLY Stock Rallies On Much Awaited FDA Approval For Weight Loss Pill</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.<div class="st-video-embed" data-video-url="https://videos.stocktwits-cdn.com/hls/2026/03/26/69ee8298-8c28-42e1-b686-43e84dc29610/fq6gh7vs9vzzy7rkkx2fll5vlsu3_download.mp4" data-thumbnail-url="" data-caption="" data-summary="" data-width="" data-height="" data-orientation="horizontal" data-duration="">&nbsp;</div>

Rising stock market chart on a trading board background.

UNCY Retail Buzz Explodes 150% This Week as Traders Bet Big on Experimental Drug Approval

UNCY has resubmitted its application seeking the U.S. Food and Drug Administration’s approval for Oxylanthanum carbonate for the treatment of hyperphosphatemia in patients with chronic kidney disease on dialysis. 

Equity

UNCY has resubmitted its application seeking the U.S. Food and Drug Administration’s approval for Oxylanthanum carbonate for the treatment of hyperphosphatemia in patients with chronic kidney disease on dialysis. 


Noble Financial Brokers Boost Earnings Estimates for UNCY

Unicycive Therapeutics, Inc. (NASDAQ:UNCY - Free Report) - Stock analysts at Noble Financial increased their Q3 2026 earnings per share estimates for Unicycive Therapeutics in a research report...

Unicycive Therapeutics (NASDAQ:UNCY) Releases Quarterly Earnings Results, Misses Estimates By $0.36 EPS

Unicycive Therapeutics (NASDAQ:UNCY - Get Free Report) released its earnings results on Monday. The company reported ($0.82) earnings per share for the quarter, missing analysts' consensus estimates...

Unicycive Therapeutics (UNCY) to Release Quarterly Earnings on Monday

Unicycive Therapeutics (NASDAQ:UNCY) will be releasing earnings before the market opens on Monday, March 30. (View Earnings Report at...

Unicycive Therapeutics (NASDAQ:UNCY) Shares Down 0.4% - Here's Why

Unicycive Therapeutics (NASDAQ:UNCY) Trading Down 0.4% - Should You Sell...

Unicycive Therapeutics, Inc. (NASDAQ:UNCY) Given Consensus Recommendation of "Moderate Buy" by Analysts

Shares of Unicycive Therapeutics, Inc. (NASDAQ:UNCY - Get Free Report) have been assigned a consensus recommendation of "Moderate Buy" from the five brokerages that are currently covering the firm...

Unicycive Therapeutics (NASDAQ:UNCY) Stock Price Up 2.4% - Should You Buy?

Unicycive Therapeutics (NASDAQ:UNCY) Stock Price Up 2.4% - Still a Buy...

Unicycive Therapeutics, Inc. engages in the development of treatment for kidney diseases. Its products include UNI-494, Renazorb, and UNI-220. The company was founded by Shalabh Gupta on August 18, 2016 and is headquartered in Los Altos, CA.

Unicycive Therapeutics Inc

Opendoor ($OPEN)

Strategy ($MSTR)

American Eagle ($AEO)

Ondas Inc. ($ONDS)

The stock that proved the power of the crowd. Fueled by community energy and social momentum, this winner captivated retail investors regardless of what the "experts" or traditional fundamentals had to say.

UNCY
Unicycive Therapeutics Inc

Feed

News

Sentiment

Fundamentals

Info

Poll

Latest UNCY News

UNCYUnicycive Therapeutics Inc